insights_auto
Why is MVIR up 2,33%?
Dive Deeperchevron_right
MVIR:STO
Medivir AB
1,49 SEK
arrow_upward
+2,33%(+0,034) 1D
9 қаз., 17:29:42 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
1,47 SEK
High
1,50 SEK
Low
1,45 SEK
Mkt. cap
932,52 млн
Avg. vol.
1,41 млн
Volume
1,73 млн
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 млн
No. of employees
6
Open
1,47 SEK
High
1,50 SEK
Low
1,45 SEK
Mkt. cap
932,52 млн
Avg. vol.
1,41 млн
Volume
1,73 млн
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 млн
No. of employees
6
News stories
From web sources and news partners
Yahoo Finance
·
19 минут бұрын
The Nasdaq-100 Has Gained 20% or More 3 Years Running. This Streak Rests on Far Stronger Earnings Than 1999's.
Kalkine Media
·
28 минут бұрын
Why Does Strategy (NASDAQ:MSTR) Matter After the Rebound?
Seeking Alpha
·
2 сағат бұрын
S&P 500 Forward Earnings Yield (5.3%) Vs. 10-Year Treasury Real Yield (3%): Which One Wins? (NASDAQ:TLT)
Detroit Free Press
·
7 сағат бұрын
How an S&P 500 high, then some reality checks hit markets this week
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB